GlassScriptPhysician profile
Derek Ludovit Vajda
NPI 1548618648
$23,487.59
in general payments reported to CMS, 2019-2025
9 companies · $4,503 in 2025
The $4,503 reported for 2025 was more than what 97% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $558 · 2022: $16K · 2023: $756 · 2024: $1,207 · 2025: $4,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,906 · Travel and Lodging: $2,058 · Entertainment: $279 · Gift: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.33 |
| Travel and Lodging | $2,057.60 |
| Entertainment | $278.96 |
| Gift | $223.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $16,376.11 | 2021-2025 | |
| Straumann USA LLC | $5,523.48 | 2024-2025 | |
| Stryker Corporation | $536.71 | 2021 | |
| Ormco Corporation | $311.44 | 2023 | |
| Nobel Biocare USA | $311.44 | 2023 | Nobelactive |
| Merz Pharmaceuticals, LLC | $133.40 | 2023 | Xeomin |
| Axogen | $129.88 | 2020 | |
| Geistlich Pharma, North America, INC. | $124.73 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $40.40 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Vajda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.